About Us Strategy & Mission Our Values Our People Our Board Our Collaborations Contact Our Programmes Overview Pipeline C. difficile Infection Gonorrhoea Enterobacteriaceae ESKAPE Programme Clinical Trials Stewardship Compassionate Use Our Science Discuva Platform Publications Investors Investor Centre Press Releases Financial Reports & Filings Email Alerts Events & Presentations Share Price Data Shareholder Information Analyst Coverage Corporate Governance AIM Rule 26 Advisers Shareholder Meetings Careers
A Novel Small Molecule Antibiotic for the Treatment of Neisseria gonorrhoeae A Novel Small Molecule Antibiotic for the Treatment of Neisseria gonorrhoeae November 13, 2018 By Michelle Avery
A Novel Small Molecule Antibiotic for the Treatment of Neisseria gonorrhoeae November 13, 2018 By Michelle Avery
